Delivery Order SPE2DB20D1100-SPE2DB25FC7S9

Award Date 6/6/25
Potential Completion Date 6/9/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication, with a ceiling value of $1,608.96 and a performance period through June 23, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,084.04, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. It is a firm fixed-price contract with a period of performance through March 31, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication, with a ceiling value of $15,704.33 and a period of performance through May 1, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. Amerisourcebergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,007.97, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of May 13, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Fluticasone Prop HFA 110 MCG 12GM, a medical product. The contract has a ceiling value of $1,084.80 and a completion date of March 5, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, with a ceiling value of $2,274.22. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, with a ceiling value of $2,912.29 and a period of performance through March 27, 2025. The contract is a Firm Fixed Price, Delivery Order contract with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication. The contract has a ceiling value of $2,391.30 and a period of performance through December 26, 2023. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, with a firm fixed price ceiling value of $1,416.34 and a completion date of May 28, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with a ceiling value of $1,891.24. The contract is a firm fixed price delivery order with a completion date of May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC7S9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication, with a ceiling value of $1,711.62. The contract is a firm fixed-price delivery order with a performance period that extends until June 9, 2025. This award is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for the military healthcare programs through December 2026.

Generated 9/5/25, 10:00 AM